Abstract presented 10/20 at American Society Nephrology mtg show IV Pegloticase use in 136 ESRD dialysis pts (Rx by Rheums 68%). Pts were 73% males, avg age 57 years, More on hemodialysis [79%] than peritoneal dialysis [17%]. Pts RCV ~13 infusions. https://t.co/SFO8duqiy8